article thumbnail

Epicardial Substrate Ablation in Symptomatic Brugada Syndrome Patients: An Updated Systematic Review and Single-arm Meta-analysis

HeartRhythm

Brugada syndrome (BrS) is a genetic heart disease that predisposes individuals to ventricular arrhythmias and sudden cardiac death. In this setting, epicardial substrate ablation has emerged as a promising alternative for symptomatic patients.

article thumbnail

News from EHRA 2024: International Experts Agree on Standards for Catheter Ablation of Atrial Fibrillation

DAIC

An international consensus statement on how to treat atrial fibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany. Image courtesy: European Society of Cardiology.

article thumbnail

Efficacy of Catheter Ablation for Ventricular Tachycardia in Ischemic Cardiomyopathy Patients without an ICD Implantation

HeartRhythm

Implantable cardioverter defibrillator (ICD) prevents sudden cardiac death (SCD) in patients with ischemic cardiomyopathy (ICM). Catheter ablation has been shown to effectively reduce ventricular tachycardia (VT) recurrence, yet its efficacy in patients without an ICD implantation remains uncertain.

article thumbnail

Ablation of Ventricular Tachycardia in Patients with ischemic cardiomyopathy and without an ICD – For the times they are a-changin´?

HeartRhythm

Recent advancements in catheter ablation for structural ventricular tachycardia (VT), such as high-density mapping and cardiac imaging-based detection of target areas, have significantly improved the efficacy of ablation procedures.

article thumbnail

Slowly conducting anatomic isthmuses of tetralogy of Fallot: An opportunity for “prophylactic” ventricular tachycardia ablation

HeartRhythm

Patients with repaired tetralogy of Fallot are at risk of ventricular tachycardia (VT) and sudden cardiac death. Historically, risk stratification electrophysiologic studies involved programmed ventricular stimulation with VT induction guiding implantable cardioverter-defibrillator (ICD) implantation or VT ablation.

article thumbnail

Characterization of Skin Sympathetic Nerve Activity in Patients Undergoing Ablation of Ventricular Tachycardia

HeartRhythm

Ventricular tachycardia (VT) is a common consequence of both ischemic and non-ischemic heart diseases, often leading to sudden cardiac death. Enhanced sympathetic nerve activity has been implicated in the initiation of VT.

article thumbnail

PO-01-146 SUCCESSFUL CATHETER ABLATION OF VENTRICULAR TACHYCARDIA BEFORE TRANSCATHETER PULMONARY VALVE IMPLANTATION IN THE PATIENT WITH REPAIRED DOUBLE OUTLET RIGHT VENTRICLE

HeartRhythm

Patients with adult congenital heart disease are at risk for ventricular arrhythmias (VAs) or sudden cardiac death.